From: A Bayesian approach to pilot-pivotal trials for bioequivalence assessment
Comparator | Mean | Standard deviation | Percentile | ||
---|---|---|---|---|---|
5.0% | 50% | 95.0% | |||
C\(_{\text {max}}\) | |||||
Ā Ā Ā Ā Ā \(\theta _2\) | 0.1721 | 3.0455 | -0.1131 | 0.1543 | 0.4507 |
Ā Ā Ā Ā Ā exp (\(\theta _2\)) | 1.1878 | 21.0205 | 0.8931 | 1.1668 | 1.5694 |
Ā Ā Ā Ā Ā pred.prob.be1 | 0.681 | 0.466 | 0 | 1.000 | 1.000 |
Ā Ā Ā Ā Ā pred.prob.be2 | 0.831 | 0.375 | 0 | 1.000 | 1.000 |
AUC | |||||
Ā Ā Ā Ā Ā \(\theta _2\) | 0.0772 | 3.0454 | -0.1332 | 0.0510 | 0.2776 |
Ā Ā Ā Ā Ā exp (\(\theta _2\)) | 1.0803 | 21.0184 | 0.8753 | 1.0523 | 1.3200 |
Ā Ā Ā Ā Ā pred.prob.be1 | 0.900 | 0.299 | 0 | 1.000 | 1.000 |
Ā Ā Ā Ā Ā pred.prob.be2 | 0.905 | 0.293 | 0 | 1.000 | 1.000 |